




Searching News Database: IBD
HSMN NewsFeed - 8 Jul 2024
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
HSMN NewsFeed - 10 Mar 2021
Novum Medical(TM) Appoints Tom Afzal as CEO and Announces Closing of Financing
Novum Medical(TM) Appoints Tom Afzal as CEO and Announces Closing of Financing
HSMN NewsFeed - 15 Feb 2021
Avexegen Therapeutics Receives a $2.94M NIH Grant to Advance Treatment for Inflammatory Bowel Disease
Avexegen Therapeutics Receives a $2.94M NIH Grant to Advance Treatment for Inflammatory Bowel Disease
HSMN NewsFeed - 24 Oct 2018
Inova Diagnostics Launches First FDA Cleared Calprotectin Extraction Device
Inova Diagnostics Launches First FDA Cleared Calprotectin Extraction Device
HSMN NewsFeed - 3 Jan 2018
Inova Diagnostics Receives FDA Clearance for the First Fully Automated, Random Access Calprotectin Test
Inova Diagnostics Receives FDA Clearance for the First Fully Automated, Random Access Calprotectin Test
HSMN NewsFeed - 10 Sep 2015
Protagonist Therapeutics Names Richard S. Shames, M.D. as Chief Medical Officer
Protagonist Therapeutics Names Richard S. Shames, M.D. as Chief Medical Officer
HSMN NewsFeed - 7 May 2013
Coronado Biosciences Appoints Thomas F. Schaible, Ph.D. as Project Leader, Inflammatory Bowel Disease
Coronado Biosciences Appoints Thomas F. Schaible, Ph.D. as Project Leader, Inflammatory Bowel Disease
HSMN NewsFeed - 9 Oct 2012
Integra LifeSciences Receives FDA Clearance for Expanded Indication for Spinal Device
Integra LifeSciences Receives FDA Clearance for Expanded Indication for Spinal Device
HSMN NewsFeed - 31 Jul 2012
Prometheus Launches New Monitoring Test To Help Guide Inflammatory Bowel Disease Management
Prometheus Launches New Monitoring Test To Help Guide Inflammatory Bowel Disease Management
HSMN NewsFeed - 2 Nov 2011
Integra LifeSciences Launches a Zero-Profile, Stand-Alone Interbody Device for Neck Surgery
Integra LifeSciences Launches a Zero-Profile, Stand-Alone Interbody Device for Neck Surgery
HSMN NewsFeed - 3 Oct 2011
Integra LifeSciences Meets Surgeon Demand for User-Friendly Minimally Invasive Spinal Solutions
Integra LifeSciences Meets Surgeon Demand for User-Friendly Minimally Invasive Spinal Solutions
HSMN NewsFeed - 11 Apr 2011
Integra LifeSciences Receives FDA Approvals for Three Spinal Fixation Devices
Integra LifeSciences Receives FDA Approvals for Three Spinal Fixation Devices
HSMN NewsFeed - 9 Jan 2009
Integra LifeSciences Launches a Series of PEEK-Optima(R) Interbody Spinal Implants
Integra LifeSciences Launches a Series of PEEK-Optima(R) Interbody Spinal Implants
HSMN NewsFeed - 11 Dec 2008
New Data Shows Zometa(R) Enhances Impact of Chemotherapy on Reducing Breast Tumour Size
New Data Shows Zometa(R) Enhances Impact of Chemotherapy on Reducing Breast Tumour Size
HSMN NewsFeed - 21 Oct 2008
New Multicenter Study Underscores Value of Using PillCam(R) SB in Children Younger Than 8
New Multicenter Study Underscores Value of Using PillCam(R) SB in Children Younger Than 8
HSMN NewsFeed - 30 Jun 2008
William D. Schwieterman, M.D. Joins Chelsea Therapeutics' Board of Directors
William D. Schwieterman, M.D. Joins Chelsea Therapeutics' Board of Directors
HSMN NewsFeed - 20 May 2008
Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients
Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients
HSMN NewsFeed - 10 Apr 2008
Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion
Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion
HSMN NewsFeed - 18 Mar 2008
Titan Spine's ENDOSKELETON(R) TA Passes Test In Competitive Lower Back Pain Market
Titan Spine's ENDOSKELETON(R) TA Passes Test In Competitive Lower Back Pain Market
HSMN NewsFeed - 12 Nov 2007
FDA Accepts Chelsea Therapeutics' Investigational New Drug Application for Droxidopa
FDA Accepts Chelsea Therapeutics' Investigational New Drug Application for Droxidopa
HSMN NewsFeed - 14 Aug 2007
European Commission Grants Chelsea Therapeutics Two Orphan Medicinal Product Designations for Droxidopa
European Commission Grants Chelsea Therapeutics Two Orphan Medicinal Product Designations for Droxidopa
Additional items found! 18

Members Archive contains
18 additional stories matching:
IBD
(Password required)
IBD
(Password required)